title: Immune reconstitution after cord blood transplants supported by coinfusion of mobilized hematopoietic stem cells from a third party donor.
abstract: Low severity of GVHD, substantial graft vs tumor (GVT) and slow development of protective immunity are well-documented features of cord blood transplants (CBT). We have evaluated the immune reconstitution of adult recipients of single-unit CBT supported by the coinfusion of third party donor (TPD) mobilized hematopoietic stem cells (MHSC), a procedure-'dual CB/TPD-MHSC transplant'-that results in early recovery of circulating granulocytes, high rates of CB engraftment and full chimerism. Cumulative recovery of natural killer and B cells at or above the median values of normal controls were 1.0 and 0.76 by the sixth and ninth months. Recovery of T cells was much slower, naive cells lagging behind those of memory and effector (committed) immunophenotypes. Serial analyses of signal joint TCR excision circles showed a general pattern of very low levels by the third month after CBT, followed by recovery to levels persistently similar or higher than those observed before transplantation and in normal controls. Our results are consistent with the clinical observations of substantial GVT effect together with low incidence of serious GVHD and slow development of protective immunity and suggest that thymic function contributes substantially to the recovery of T-cell populations in adults receiving dual CB/TPD-MHSC transplants.
authors.affiliation: Department of Hematology, Hospital Universitario Puerta de Hierro, Universidad Autónoma de Madrid, Madrid, Spain.
authors.forename: T
authors.initials: T
authors.lastname: Martín-Donaire
authors.forename: M
authors.initials: M
authors.lastname: Rico
authors.forename: G
authors.initials: G
authors.lastname: Bautista
authors.forename: R
authors.initials: R
authors.lastname: Gonzalo-Daganzo
authors.forename: C
authors.initials: C
authors.lastname: Regidor
authors.forename: E
authors.initials: E
authors.lastname: Ojeda
authors.forename: I
authors.initials: I
authors.lastname: Sanjuán
authors.forename: R
authors.initials: R
authors.lastname: Forés
authors.forename: E
authors.initials: E
authors.lastname: Ruiz
authors.forename: I
authors.initials: I
authors.lastname: Krsnik
authors.forename: B
authors.initials: B
authors.lastname: Navarro
authors.forename: S
authors.initials: S
authors.lastname: Gil
authors.forename: E
authors.initials: E
authors.lastname: Magro
authors.forename: I
authors.initials: I
authors.lastname: Millán
authors.forename: R
authors.initials: R
authors.lastname: Sánchez
authors.forename: N
authors.initials: N
authors.lastname: Pérez-Sanz
authors.forename: N
authors.initials: N
authors.lastname: Panadero
authors.forename: J A
authors.initials: JA
authors.lastname: García-Marco
authors.forename: R
authors.initials: R
authors.lastname: Cabrera
authors.forename: M N
authors.initials: MN
authors.lastname: Fernández
mesh_terms: D000328:Adult; D036101:Cord Blood Stem Cell Transplantation / Q000379:methods*; D018572:Disease-Free Survival; D005260:Female; D006085:Graft Survival / Q000276:immunology; D006086:Graft vs Host Disease / Q000276:immunology; D019337:Hematologic Neoplasms / Q000276:immunology / Q000601:surgery*; D019650:Hematopoietic Stem Cell Mobilization; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006650:Histocompatibility Testing; D006801:Humans; D053208:Kaplan-Meier Estimate; D019520:Living Donors; D008213:Lymphocyte Activation / Q000276:immunology; D008297:Male; D008875:Middle Aged; D019172:Transplantation Conditioning; D014181:Transplantation Immunology; D055815:Young Adult